Molecular Carcinogenesis

• 

  Publication Venue For

  • Genetic variants in DDO and PEX5L in peroxisome-related pathways predict non-small cell lung cancer survival..  61:619-628. 2022
  • NUAK family kinase 2 is a novel therapeutic target for prostate cancer..  61:334-345. 2022
  • Association of genetic variants of FBXO32 and FOXO6 in the FOXO pathway with breast cancer risk..  60:661-670. 2021
  • Effects of checkpoint kinase 1 inhibition by prexasertib on the tumor immune microenvironment of head and neck squamous cell carcinoma..  60:138-150. 2021
  • Genetic variants of the peroxisome proliferator-activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer..  59:930-939. 2020
  • Genetic variants in PDSS1 and SLC16A6 of the ketone body metabolic pathway predict cutaneous melanoma-specific survival..  59:640-650. 2020
  • Novel genetic variants in HDAC2 and PPARGC1A of the CREB-binding protein pathway predict survival of non-small-cell lung cancer..  59:104-115. 2020
  • Syntaxin 6-mediated exosome secretion regulates enzalutamide resistance in prostate cancer..  59:62-72. 2020
  • A genetic variant within MDM4 3'UTR miRNA binding site is associated with HPV16-positive tumors and survival of oropharyngeal cancer..  58:2276-2285. 2019
  • Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma-specific survival..  58:2091-2103. 2019
  • Genetic variants in the liver kinase B1-AMP-activated protein kinase pathway genes and pancreatic cancer risk..  58:1338-1348. 2019
  • Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial..  58:1094-1104. 2019
  • Genetic variants in nucleotide excision repair pathway predict survival of esophageal squamous cell cancer patients receiving platinum-based chemotherapy..  57:1553-1565. 2018
  • Associations between expression levels of nucleotide excision repair proteins in lymphoblastoid cells and risk of squamous cell carcinoma of the head and neck..  57:784-793. 2018
  • Mouse double minute 4 variants modify susceptibility to risk of recurrence in patients with squamous cell carcinoma of the oropharynx..  57:361-369. 2018
  • Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer..  57:216-224. 2018
  • Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival..  57:22-31. 2018
  • Functional genetic variants of XRCC4 and ERCC1 predict survival of gastric cancer patients treated with chemotherapy by regulating the gene expression..  56:2706-2717. 2017
  • Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus..  56:1663-1672. 2017
  • E2F transcription factor 2 variants as predictive biomarkers for recurrence risk in patients with squamous cell carcinoma of the oropharynx..  56:1335-1343. 2017
  • Susceptibility loci of CNOT6 in the general mRNA degradation pathway and lung cancer risk-A re-analysis of eight GWASs..  56:1227-1238. 2017
  • A functional variant at the miRNA binding site in E2F1 gene is associated with risk and tumor HPV16 status of oropharynx squamous cell carcinoma..  56:1100-1106. 2017
  • The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target..  55:335-345. 2016
  • Genetic polymorphisms in the microRNA binding-sites of the thymidylate synthase gene predict risk and survival in gastric cancer..  54:880-888. 2015
  • Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinoma..  54:900-907. 2015
  • A novel mechanism of skin tumor promotion involving interferon-gamma (IFNγ)/signal transducer and activator of transcription-1 (Stat1) signaling..  54:642-653. 2015
  • Two novel PRKCI polymorphisms and prostate cancer risk in an Eastern Chinese Han population..  54:632-641. 2015
  • Dishevelled-3 activates p65 to upregulate p120-catenin transcription via a p38-dependent pathway in non-small cell lung cancer..  54 Suppl 1:E112-E121. 2015
  • Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer..  54:449-458. 2015
  • Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-Hispanic white women aged ≤ 55 years..  54:281-290. 2015
  • Constitutive Stat3 activation alters behavior of hair follicle stem and progenitor cell populations..  54:121-133. 2015
  • Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma..  54:35-49. 2015
  • Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction..  52 Suppl 1:E139-E147. 2013
  • Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population..  52 Suppl 1:E70-E79. 2013
  • Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer..  52:890-899. 2013
  • Combined effects of E2F1 and E2F2 polymorphisms on risk and early onset of squamous cell carcinoma of the head and neck..  51 Suppl 1:E132-E141. 2012
  • Functional polymorphisms in the insulin-like binding protein-3 gene may modulate susceptibility to differentiated thyroid carcinoma in Caucasian Americans..  51 Suppl 1:E158-E167. 2012
  • Genetic variants of a BH3-only pro-apoptotic gene, PUMA, and risk of HPV16-associated squamous cell carcinoma of the head and neck..  51 Suppl 1:E54-E64. 2012
  • Single nucleotide polymorphisms of matrix metallopeptidase 3 and risk of gliomas in a Chinese Han population..  51 Suppl 1:E1-10. 2012
  • DNA mismatch repair network gene polymorphism as a susceptibility factor for pancreatic cancer..  51:491-499. 2012
  • Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck..  50:697-706. 2011
  • Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk..  50:397-402. 2011
  • Association between polymorphisms in the GSTA4 gene and risk of lung cancer: a case-control study in a Southeastern Chinese population..  48:253-259. 2009
  • Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers..  47:701-706. 2008